DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
34	神経線維腫症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00326872 (ClinicalTrials.gov)	May 2006	16/5/2006	AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine	A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas	Neurofibromatosis Type 1;Plexiform Neurofibroma;Spinal Cord Neurofibroma	Drug: Cediranib Maleate	National Cancer Institute (NCI)	NULL	Terminated	18 Years	N/A	All	26	Phase 2	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

May 2006

16/5/2006

AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine

A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas

Neurofibromatosis Type 1;Plexiform Neurofibroma;Spinal Cord Neurofibroma

Drug: Cediranib Maleate

National Cancer Institute (NCI)

NULL

Terminated

18 Years

N/A

All

Phase 2

United States